ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2180

Salivary and Plasma Mitochondrial Double-strand RNAs as a Diagnostic Biomarker for Sjӧgren Syndrome

SE RIM CHOI1, Jee-in Lee2, Yong Seok Choi3, You-Jung Ha3, Eun Ha Kang3 and Yun Jong Lee4, 1Seoul National University Bundang Hospital, Seoul, South Korea, 2Seoul National University of Bundang Hospital, Seongnam, South Korea, 3Seoul National University Bundang Hospital, Seongnam, South Korea, 4Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam-si, South Korea

Meeting: ACR Convergence 2023

Keywords: Biomarkers, Gene Expression, Sjögren's syndrome

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 14, 2023

Title: (2177–2194) Sjögren’s Syndrome – Basic & Clinical Science Poster II

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Since mitochondrial double-stranded RNAs (mt-dsRNAs), an endogenous activator of interferon signaling, are elevated in primary Sjӧgren’s syndrome (pSS), we evaluated their association with the expression levels of interferon-inducible genes (IFIGs) and their diagnostic performance.

Methods: One hundred four pSS patients satisfying the 2016 ACR/EULAR criteria, 14 non-SS sicca patients, and 25 healthy controls were included. Seven mt-dsRNAs levels (CYTB, ND1, CO1, ND4, CO2, ND5, and ND6) in unstimulated whole saliva (UWS) and plasma samples and 8 IFIGs (IFIT1, IFIT3, IFI44, IFI44L, LY6E, OAS1, MX1, and ISG15) levels in peripheral blood mononuclear cells (PBMCs) were measured using RT-PCR. Z-score-based standardized mt-dsRNAs and IFIGs scoring systems were constructed using multivariate logistic regressions. The area under the ROC curve (AUC), sensitivity and specificity, andYouden’s index were calculated.

Results: mt-dsRNAs ND1 and ND6 in UWS and ND1 and ND4 in plasma and IFIT1, IFIT3, IFI44L, and OAS1 in PMBCs remained to be significantly associated with pSS. The mt-dsRNA score was defined as (2.16´ND1)−(1.87´ND6) in UWS and (−1.09´ND1)+(0.74´ND6) in plasma. The IFIG score in PBMC was calculated using (0.80´IFIT1)+(0.83´IFIT3)+(0.76´IFI44L) −(1.25´OAS1). Despite that they were derived from different samples, all three scores were significantly correlated mutually. The AUC of UWS (0.924) and plasma (0.874) mt-dsRNA scores were larger than that of PMBC IFIG score (0.817). With the optimal cut-off of 1.71, the sensitivity and specificity of UWS mt-dsRNA score were 97.4% and 89.7%, respectively.

Conclusion: Increased transcript levels of some mt-dsRNA in UWS and plasma were significantly associated with pSS. A novel mt-dsRNA scoring system could be a potential diagnostic marker for pSS diagnosis.

Supporting image 1

Table 1. Results of multivariate logistic regressions.
UWS = unstimulated whole saliva; OR = odds ratio; CI = confidence interval; PBMC = peripheral blood mononuclear cell

Supporting image 2

Figure 1. Correlation between mt-dsRNA scores and IFIG scores (A) and ROC curves of mt-dsRNA and IFIG scores for in primary Sjӧgren’s syndrome.
IFIG = interferon inducible genes; mt-dsRNA = mitochondrial double strand RNA; PBMC = peripheral blood mononuclear cell; SS = Sjӧgren’s syndrome; UWS = unstimulated whole saliva

Supporting image 3

Table 2. Diagnostic performance of mt-dsRNA and IFIG scores in Sjӧgren’s syndrome
AUC = area under the curve; CI = confidence interval; IFIG = interferon inducible genes; mt-dsRNA = mitochondrial double strand RNA; PBMC = peripheral blood mononuclear cell; SS = Sjӧgren’s syndrome; UWS = unstimulated whole saliva


Disclosures: S. CHOI: None; J. Lee: None; Y. Choi: None; Y. Ha: None; E. Kang: None; Y. Lee: None.

To cite this abstract in AMA style:

CHOI S, Lee J, Choi Y, Ha Y, Kang E, Lee Y. Salivary and Plasma Mitochondrial Double-strand RNAs as a Diagnostic Biomarker for Sjӧgren Syndrome [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/salivary-and-plasma-mitochondrial-double-strand-rnas-as-a-diagnostic-biomarker-for-sj%d3%a7gren-syndrome/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/salivary-and-plasma-mitochondrial-double-strand-rnas-as-a-diagnostic-biomarker-for-sj%d3%a7gren-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology